Similarly, PTEN gene nanovectors are being investigated for lung cancer [166], while clinical studies in prostate cancer have demonstrated the ability of PTEN gene therapy to enhance chemotherapy efficacy [167]. This evidence concerns the gene PTEN and prostate carcinoma.